• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质对低质量平衡化合物在 Caco-2 通透性的影响,用于吸收预测和外排底物鉴定。

The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.

机构信息

Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA.

出版信息

J Pharm Biomed Anal. 2010 Apr 6;51(5):1069-77. doi: 10.1016/j.jpba.2009.12.006. Epub 2009 Dec 24.

DOI:10.1016/j.jpba.2009.12.006
PMID:20036089
Abstract

This study was to evaluate the mechanistic effect of protein to help better interpret the permeability results for compounds with low mass balance in Caco-2 permeability assay. The absorptive or bi-directional permeability of lipophilic compounds with mass balance were measured across Caco-2 cell monolayers as well as the empty transport devices with or without protein (4% bovine serum albumin, BSA) added to the receiver side. The results from empty transport device study indicated that the filter membrane is a permeability barrier for the low mass balance compounds and protein increases permeability by improving the compound diffusivity through the filter membrane. Caco-2 permeability measured with protein provided better absorption projection. Assuming the amount of compound associated with cells as transported did not correlate with absorption. For efflux substrate identification using Caco-2 bi-directional permeability assay, protein at the receiver side had no significant effect on the conclusion regarding the tested compounds as efflux substrate but increased the permeability measurement from both transport directions. In conclusions, Caco-2 permeability results measured using protein-containing buffer at the receiver side for low mass balance compound seems to provide better correlation with in vivo absorption. The fact that protein at receiver side has minimal effect on efflux substrate identification provides scientific basis for further specific transporter characterization (such as P-gp or BCRP) using specific inhibitors, in which same concentration of inhibitor is used in both sides of the Caco-2 cell system and protein for optimal permeability assessment has to be avoided.

摘要

本研究旨在评估蛋白质的作用机制,以便更好地解释在 Caco-2 渗透率测定中质量平衡低的化合物的渗透率结果。通过向接收侧添加蛋白质(4%牛血清白蛋白,BSA),测量具有质量平衡的亲脂性化合物的吸收或双向渗透率,以及在有空运输装置和无空运输装置的情况下。空运输装置研究的结果表明,滤膜是低质量平衡化合物的渗透屏障,蛋白质通过提高化合物通过滤膜的扩散性来增加渗透性。用蛋白质测量的 Caco-2 渗透率提供了更好的吸收预测。假设与细胞结合的化合物的量与吸收无关。对于使用 Caco-2 双向渗透率测定法鉴定外排底物,接收侧的蛋白质对作为外排底物的测试化合物的结论没有显著影响,但增加了来自两个运输方向的渗透率测量。总之,对于质量平衡低的化合物,在接收侧使用含蛋白质的缓冲液测量 Caco-2 渗透率似乎与体内吸收具有更好的相关性。接收侧的蛋白质对鉴定外排底物几乎没有影响,为使用特定抑制剂进一步进行特定转运体特征描述(如 P-糖蛋白或 BCRP)提供了科学依据,在这种情况下,抑制剂的相同浓度用于 Caco-2 细胞系统的两侧,并且必须避免蛋白质以获得最佳的渗透性评估。

相似文献

1
The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.蛋白质对低质量平衡化合物在 Caco-2 通透性的影响,用于吸收预测和外排底物鉴定。
J Pharm Biomed Anal. 2010 Apr 6;51(5):1069-77. doi: 10.1016/j.jpba.2009.12.006. Epub 2009 Dec 24.
2
Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.使用模拟肠液进行亲脂性药物的Caco-2渗透性测定。
Int J Pharm. 2008 Aug 6;360(1-2):148-55. doi: 10.1016/j.ijpharm.2008.04.034. Epub 2008 Apr 29.
3
Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.由于P-糖蛋白导致低渗透性化合物沿小肠的节段依赖性转运:外排转运在BCS III类药物口服吸收中的作用
Mol Pharm. 2009 Jan-Feb;6(1):19-28. doi: 10.1021/mp800088f.
4
Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.模拟肠液对药物透过Caco-2单层细胞的渗透性评估的影响。
Int J Pharm. 2004 Apr 15;274(1-2):221-32. doi: 10.1016/j.ijpharm.2004.01.014.
5
Evaluation of cocktail approach to standardise Caco-2 permeability experiments.评估用于标准化Caco-2细胞渗透性实验的混合方法。
Eur J Pharm Biopharm. 2006 Nov;64(3):379-87. doi: 10.1016/j.ejpb.2006.06.006. Epub 2006 Jun 30.
6
Caco-2/TC7 cell line characterization for intestinal absorption: how reliable is this in vitro model for the prediction of the oral dose fraction absorbed in human?Caco-2/TC7 细胞系用于肠道吸收特征描述:该体外模型对于预测人体口服剂量分数吸收的可靠性如何?
Toxicol In Vitro. 2011 Feb;25(1):13-20. doi: 10.1016/j.tiv.2010.08.009. Epub 2010 Aug 21.
7
Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa.用于预测化合物跨人肠黏膜吸收的体外模型比较
J Biomol Screen. 2004 Oct;9(7):598-606. doi: 10.1177/1087057104267162.
8
A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay.一种基于细胞的联合方法,可在单一检测中鉴定P-糖蛋白底物和抑制剂。
Int J Pharm. 2005 Sep 14;301(1-2):80-8. doi: 10.1016/j.ijpharm.2005.05.034.
9
Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.P-糖蛋白在限制药物肠道吸收中的功能作用:被动通透性对P-糖蛋白介导的外排转运的贡献。
Mol Pharm. 2005 Jan-Feb;2(1):12-21. doi: 10.1021/mp0499196.
10
Permeability evaluation of peptidic HCV protease inhibitors in Caco-2 cells-correlation with in vivo absorption predicted in humans.肽类丙型肝炎病毒蛋白酶抑制剂在Caco-2细胞中的渗透性评估——与人类体内吸收预测的相关性
Biochem Pharmacol. 2008 Dec 15;76(12):1757-64. doi: 10.1016/j.bcp.2008.09.005. Epub 2008 Sep 13.

引用本文的文献

1
Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs.口服生物可利用的蛋白酶靶向嵌合体:小分子抗癌药物发现黄金时代的一种创新方法。
Pharmaceuticals (Basel). 2024 Apr 12;17(4):494. doi: 10.3390/ph17040494.
2
Principles and Experimental Considerations for In Vitro Transporter Interaction Assays.体外转运体相互作用检测的原理和实验考虑。
Methods Mol Biol. 2021;2342:339-365. doi: 10.1007/978-1-0716-1554-6_13.
3
Cannabidiol Isolated From L. Protects Intestinal Barrier From Inflammation and Oxidative Stress.
从L.中分离出的大麻二酚可保护肠道屏障免受炎症和氧化应激的影响。
Front Pharmacol. 2021 Apr 28;12:641210. doi: 10.3389/fphar.2021.641210. eCollection 2021.
4
Sangiovese Pomace Seeds Extract-Fortified Kefir Exerts Anti-Inflammatory Activity in an Model of Intestinal Epithelium Using Caco-2 Cells.桑娇维塞果渣籽提取物强化的开菲尔在使用Caco-2细胞的肠上皮模型中发挥抗炎活性。
Antioxidants (Basel). 2020 Jan 8;9(1):54. doi: 10.3390/antiox9010054.
5
Effects of Roxb. and L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2.罗汉果和罗勒在使用免疫细胞和Caco-2细胞的体外肠道炎症模型中的作用。
Pharmaceuticals (Basel). 2018 Nov 20;11(4):126. doi: 10.3390/ph11040126.
6
Using Human Plasma as an Assay Medium in Caco-2 Studies Improves Mass Balance for Lipophilic Compounds.在 Caco-2 研究中使用人血浆作为检测介质可改善亲脂性化合物的质量平衡。
Pharm Res. 2018 Sep 17;35(11):210. doi: 10.1007/s11095-018-2493-3.